Ten23 Expands Sterile Manufacturing Capacity at VIVA 1 Facility
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
Novo Nordisk Acquires Embark Biotech
Novo Nordisk receives the full rights to develop and commercialize the lead program.
485 Route 1 South,Building F, Suite 210Iselin, NJ 08830